CardioDx

CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, is committed to developing clinically validated tests that empower clinicians to better tailor care to each individual patient. Strategically focused on coronary artery disease, CardioDx is committed to expanding patient access and improving healthcare quality and efficiency through the commercialization of genomic technologies.
Type
Private
HQ
Redwood City, US
Founded
2004
Employees
144 (est)-2%
CardioDx was founded in 2004 and is headquartered in Redwood City, US

Key People at CardioDx

Andrew Guggenhime

Andrew Guggenhime

CFO
Susan Daniels

Susan Daniels

VP, Development
David Chernoff

David Chernoff

Chief Medical Officer
Gwen Carscadden

Gwen Carscadden

VP, Human Resources
David Levison

David Levison

Founder & President & CEO
Deborah L. Kilpatrick

Deborah L. Kilpatrick

Chief Commercial Officer

CardioDx Locations

Redwood City, US
Greensboro, US

CardioDx Metrics

CardioDx Summary

Founding Date

2004

Total Funding

$284 M

Latest funding size

$12.4 M

Time since last funding

10 months

Investors

CardioDx's latest funding round of $12.4 M was in February 2016. In total, CardioDx has raised $284 M.

CardioDx Company Life

You may also be interested in